Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $43000.0.

  • Standard Biotools' Other Operating Expenses rose 10015.96% to $43000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.6 million, marking a year-over-year increase of 8282.93%. This contributed to the annual value of -$168.7 million for FY2024, which is 266.25% down from last year.
  • Latest data reveals that Standard Biotools reported Other Operating Expenses of $43000.0 as of Q3 2025, which was up 10015.96% from $271000.0 recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Other Operating Expenses registered a high of $18.0 million during Q4 2021, and its lowest value of -$57.7 million during Q2 2024.
  • Over the past 5 years, Standard Biotools' median Other Operating Expenses value was $9000.0 (recorded in 2022), while the average stood at -$16.0 million.
  • Per our database at Business Quant, Standard Biotools' Other Operating Expenses tumbled by 45792222.22% in 2023 and then surged by 10224.71% in 2025.
  • Quarter analysis of 5 years shows Standard Biotools' Other Operating Expenses stood at $18.0 million in 2021, then tumbled by 99.95% to $9000.0 in 2022, then tumbled by 614322.22% to -$55.3 million in 2023, then soared by 38.41% to -$34.0 million in 2024, then surged by 100.13% to $43000.0 in 2025.
  • Its last three reported values are $43000.0 in Q3 2025, $271000.0 for Q2 2025, and $1.1 million during Q1 2025.